Form 13-F position report

TRILLIUM THERAPEUTICS INC

Reported by JANUS HENDERSON GROUP PLC

CUSIP 89620X506 Manager CIK 0001274173

Reported 0 shares, down 429,262 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2017
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 3 Through Q4 2017

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for TRILLIUM THERAPEUTICS INC held by JANUS HENDERSON GROUP PLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

30 managers reported TRILLIUM THERAPEUTICS INC for Q4 2017.

Managers reporting TRILLIUM THERAPEUTICS INC in Q4 2017.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Matrix Capital Management Company LP New 2,173,000 +2,173,000 0.56% $15,754,000 1 qtr
NEA Management Company LLC Added 1,250,000 +200,000 0.38% $9,063,000 3 qtrs
AWM Investment Company Inc Reduced 969,138 -110,480 1.37% $7,075,000 3 qtrs
Cormorant Asset Management LP Unchanged 600,000 0 0.46% $4,380,000 3 qtrs
Tekla Capital Management LLC Reduced 450,000 -50,000 0.13% $3,285,000 3 qtrs
BAKER BROS ADVISORS LP Reduced 409,323 -4,374 0.03% $2,968,000 10 qtrs
New Leaf Venture Partners L L C Unchanged 404,159 0 1.37% $2,930,000 7 qtrs
VICTORY CAPITAL MANAGEMENT INC Added 218,971 +72,950 < 0.01% $1,598,000 5 qtrs
MORGAN STANLEY Added 160,855 +99,985 < 0.01% $1,167,000 12 qtrs
RENAISSANCE TECHNOLOGIES LLC New 157,022 +157,022 < 0.01% $1,138,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2017
Filed
February 09, 2018
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.